Active substance
Results for the substance mecasermin
1 result
About this active substance
Mecasermin is a synthetic form of insulin-like growth factor 1 (IGF-1) used for the treatment of primary IGF-1 deficiency in children and adolescents. This rare condition can lead to growth delays and other developmental issues.
Mecasermin works by stimulating bone and tissue growth, helping to improve height and overall development. The medication is administered as a subcutaneous injection, usually twice daily, as directed by a doctor.
It is important for the treatment to be closely monitored to avoid hypoglycemia, a common side effect of mecasermin. Patients should consume food before taking the medication to reduce this risk.
Side effects may include headaches, nausea, or injection site reactions. This medication is not recommended for patients with active tumors or hypersensitivity to its ingredients.
Mecasermin works by stimulating bone and tissue growth, helping to improve height and overall development. The medication is administered as a subcutaneous injection, usually twice daily, as directed by a doctor.
It is important for the treatment to be closely monitored to avoid hypoglycemia, a common side effect of mecasermin. Patients should consume food before taking the medication to reduce this risk.
Side effects may include headaches, nausea, or injection site reactions. This medication is not recommended for patients with active tumors or hypersensitivity to its ingredients.